These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16762801)

  • 1. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).
    Masson S; Latini R; Anand IS; Barlera S; Judd D; Salio M; Perticone F; Perini G; Tognoni G; Cohn JN;
    J Card Fail; 2006 Jun; 12(5):375-80. PubMed ID: 16762801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).
    Masson S; Latini R; Anand IS; Barlera S; Angelici L; Vago T; Tognoni G; Cohn JN;
    J Am Coll Cardiol; 2008 Sep; 52(12):997-1003. PubMed ID: 18786480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein in heart failure: prognostic value and the effect of valsartan.
    Anand IS; Latini R; Florea VG; Kuskowski MA; Rector T; Masson S; Signorini S; Mocarelli P; Hester A; Glazer R; Cohn JN;
    Circulation; 2005 Sep; 112(10):1428-34. PubMed ID: 16129801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure.
    Gwechenberger M; Hülsmann M; Berger R; Graf S; Springer C; Stanek B; Pacher R
    J Heart Lung Transplant; 2004 Jul; 23(7):839-44. PubMed ID: 15261178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
    Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
    Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
    Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
    Staszewsky L; Wong M; Masson S; Barlera S; Carretta E; Maggioni AP; Anand IS; Cohn JN; Tognoni G; Latini R;
    J Card Fail; 2007 Dec; 13(10):797-804. PubMed ID: 18068611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
    Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
    J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
    Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
    Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
    Voors AA; Petrie CJ; Petrie MC; Charlesworth A; Hillege HL; Zijlstra F; McMurray JJ; van Veldhuisen DJ
    Eur Heart J; 2005 Sep; 26(17):1759-64. PubMed ID: 15833758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change of N-terminal pro-brain natriuretic peptide and big endothelin in patients undergoing coronary artery bypass grafting].
    Lu YF; Qi HW; Tang CZ; Wu MY; Wang Y; Zhao FH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):667-70. PubMed ID: 17996134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
    Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR
    Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.
    Latini R; Masson S; Anand IS; Missov E; Carlson M; Vago T; Angelici L; Barlera S; Parrinello G; Maggioni AP; Tognoni G; Cohn JN;
    Circulation; 2007 Sep; 116(11):1242-9. PubMed ID: 17698733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT).
    Baruch L; Glazer RD; Aknay N; Vanhaecke J; Heywood JT; Anand I; Krum H; Hester A; Cohn JN
    Am Heart J; 2004 Dec; 148(6):951-7. PubMed ID: 15632877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT.
    Krum H; Latini R; Maggioni AP; Anand I; Masson S; Carretta E; Ingrillì F; Pettinati G; Glazer R; Tognoni G; Cohn J
    Int J Cardiol; 2007 Jun; 119(1):48-53. PubMed ID: 17049646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.
    Jourdain P; Jondeau G; Funck F; Gueffet P; Le Helloco A; Donal E; Aupetit JF; Aumont MC; Galinier M; Eicher JC; Cohen-Solal A; Juillière Y
    J Am Coll Cardiol; 2007 Apr; 49(16):1733-9. PubMed ID: 17448376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.